POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 69 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,197,321 | +58.4% | 503,076 | +17.1% | 0.00% | – |
| Q2 2023 | $756,054 | -5.9% | 429,576 | +64.7% | 0.00% | – |
| Q1 2023 | $803,098 | -42.7% | 260,746 | -1.4% | 0.00% | – |
| Q4 2022 | $1,402,258 | +53.1% | 264,577 | +2.0% | 0.00% | – |
| Q3 2022 | $916,000 | +167.8% | 259,291 | +95.8% | 0.00% | – |
| Q2 2022 | $342,000 | -65.3% | 132,419 | -39.8% | 0.00% | – |
| Q1 2022 | $987,000 | -31.6% | 220,090 | +3.9% | 0.00% | – |
| Q4 2021 | $1,443,000 | -5.3% | 211,761 | +1.4% | 0.00% | – |
| Q3 2021 | $1,524,000 | +18.7% | 208,935 | +63.1% | 0.00% | – |
| Q2 2021 | $1,284,000 | -5.0% | 128,065 | -9.5% | 0.00% | – |
| Q1 2021 | $1,352,000 | +37.7% | 141,516 | +58.2% | 0.00% | – |
| Q4 2020 | $982,000 | +25.7% | 89,478 | +1.7% | 0.00% | – |
| Q3 2020 | $781,000 | – | 87,978 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $2,692,000 | 1.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,606 | $982,000 | 0.30% |
| Pentwater Capital Management LP | 4,967,227 | $12,815,000 | 0.15% |
| Atom Investors LP | 55,827 | $144,000 | 0.06% |
| Corton Capital Inc. | 14,978 | $39,000 | 0.04% |
| Forefront Analytics, LLC | 23,370 | $61,000 | 0.03% |
| Delphia (USA) Inc. | 15,799 | $41,000 | 0.03% |
| Advisory Services Network, LLC | 259,571 | $670,000 | 0.02% |
| Laurion Capital Management LP | 545,700 | $1,408,000 | 0.02% |
| MCF Advisors LLC | 59,659 | $154,000 | 0.02% |